Oligonucleotide Synthesis Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global oligonucleotide synthesis market looks promising with opportunities in research, diagnostic, and therapeutic applications. The global oligonucleotide synthesis market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global oligonucleotide synthesis market report, please download the report brochure.
In this market, synthesized oligonucleotides is the largest offering of oligonucleotide systhesis, whereas hospitals is the largest application. Growth in various segments of the oligonucleotide systhesis market are given below:
The study includes trends and forecast for the global oligonucleotide synthesis market by offering, application, end user, and region as follows:
By Offering [Value ($ Million) shipment analysis for 2014 – 2025]:
Synthesized OligonucleotidesProductsOligonucleotide-Based DrugsPrimersProbesLarge-Scale Synthesis OligonucleotidesIntermediate-Scale Synthesis OligonucleotidesLinkers & AdaptorsServicesCustom OligonucleotidesPre-Designed OligonucleotidesReagents & ConsumablesEquipment
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
ResearchPCR (Polymerase Chain Reaction)qPCR (Quantitative Polymerase Chain Reaction)SequencingGene SynthesisOther Research ApplicationsDiagnosticsTherapeuticsDNA & Antisense Oligonucleotide-Based TherapiesRNAi Oligonucleotide-Based TherapiesCPG Oligonucleotide-Based Therapies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Research InstitutesPharmaceutical & Biotechnology CompaniesDiagnostic LaboratoriesHospitals
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the oligonucleotide synthesis companies profiled in this report include General Electric, Merck, Eurofins Scientific, Agilent Technologies, LGC Biosearch Technologies, Integrated DNA Technologies, GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec.
Lucintel forecasts that synthesized oligonucleotides will remain the largest offering segment over the forecast period due to rising research and development activities related to oligonucleotide-based drugs.
Within this market, hospitals will remain the largest end user segment over the forecast period due to a significant number of inpatient and outpatient visits and increasing prevalance of cancer and infectious diseases.
North America will remain the largest region over the forecast period due to rising research and development activities related to life science and the increasing number of oligonucleotide-based drugs/therapies being approved by the FDA (Food and Drug Administration) in the region.
Features of the Global Oligonucleotide Synthesis Market
Market Size Estimates: Global oligonucleotide synthesis market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global oligonucleotide synthesis market size by various segments, such as offering, application, and end user in terms of value.Regional Analysis: Global oligonucleotide synthesis market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different offering, application, end user, and region for the global oligonucleotide synthesis market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global oligonucleotide synthesis market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global oligonucleotide synthesis market by offering (synthesized oligonucleotides (products (oligonucleotide-based drugs, primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors), services (custom oligonucleotides and pre-designed oligonucleotides), reagents & consumables, and equipment), application (research (PCR, qPCR, sequencing, gene synthesis, and other research applications), diagnostics, therapeutics (DNA & antisense oligonucleotide-based therapies, RNAi oligonucleotide-based therapies, and CPG oligonucleotide-based therapies)), end user (academic & research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and hospitals), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global oligonucleotide synthesis market?
Q.5 What are the business risks and threats to the global oligonucleotide synthesis market?
Q.6 What are emerging trends in this oligonucleotide synthesis market and the reasons behind them?
Q.7 What are some changing demands of customers in this oligonucleotide synthesis market?
Q.8 What are the new developments in this oligonucleotide synthesis market? Which companies are leading these developments?
Q.9 Who are the major players in this oligonucleotide synthesis market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this oligonucleotide synthesis market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global oligonucleotide synthesis market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Offering (Synthesized Oligonucleotides, Reagents & Consumables, and Equipment), Application (Research, Diagnostics, Therapeutics), and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global oligonucleotide synthesis market looks promising with opportunities in research, diagnostic, and therapeutic applications. The global oligonucleotide synthesis market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global oligonucleotide synthesis market report, please download the report brochure.
In this market, synthesized oligonucleotides is the largest offering of oligonucleotide systhesis, whereas hospitals is the largest application. Growth in various segments of the oligonucleotide systhesis market are given below:
The study includes trends and forecast for the global oligonucleotide synthesis market by offering, application, end user, and region as follows:
By Offering [Value ($ Million) shipment analysis for 2014 – 2025]:
Synthesized OligonucleotidesProductsOligonucleotide-Based DrugsPrimersProbesLarge-Scale Synthesis OligonucleotidesIntermediate-Scale Synthesis OligonucleotidesLinkers & AdaptorsServicesCustom OligonucleotidesPre-Designed OligonucleotidesReagents & ConsumablesEquipment
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
ResearchPCR (Polymerase Chain Reaction)qPCR (Quantitative Polymerase Chain Reaction)SequencingGene SynthesisOther Research ApplicationsDiagnosticsTherapeuticsDNA & Antisense Oligonucleotide-Based TherapiesRNAi Oligonucleotide-Based TherapiesCPG Oligonucleotide-Based Therapies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Research InstitutesPharmaceutical & Biotechnology CompaniesDiagnostic LaboratoriesHospitals
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the oligonucleotide synthesis companies profiled in this report include General Electric, Merck, Eurofins Scientific, Agilent Technologies, LGC Biosearch Technologies, Integrated DNA Technologies, GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec.
Lucintel forecasts that synthesized oligonucleotides will remain the largest offering segment over the forecast period due to rising research and development activities related to oligonucleotide-based drugs.
Within this market, hospitals will remain the largest end user segment over the forecast period due to a significant number of inpatient and outpatient visits and increasing prevalance of cancer and infectious diseases.
North America will remain the largest region over the forecast period due to rising research and development activities related to life science and the increasing number of oligonucleotide-based drugs/therapies being approved by the FDA (Food and Drug Administration) in the region.
Features of the Global Oligonucleotide Synthesis Market
Market Size Estimates: Global oligonucleotide synthesis market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global oligonucleotide synthesis market size by various segments, such as offering, application, and end user in terms of value.Regional Analysis: Global oligonucleotide synthesis market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different offering, application, end user, and region for the global oligonucleotide synthesis market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global oligonucleotide synthesis market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global oligonucleotide synthesis market by offering (synthesized oligonucleotides (products (oligonucleotide-based drugs, primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors), services (custom oligonucleotides and pre-designed oligonucleotides), reagents & consumables, and equipment), application (research (PCR, qPCR, sequencing, gene synthesis, and other research applications), diagnostics, therapeutics (DNA & antisense oligonucleotide-based therapies, RNAi oligonucleotide-based therapies, and CPG oligonucleotide-based therapies)), end user (academic & research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and hospitals), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global oligonucleotide synthesis market?
Q.5 What are the business risks and threats to the global oligonucleotide synthesis market?
Q.6 What are emerging trends in this oligonucleotide synthesis market and the reasons behind them?
Q.7 What are some changing demands of customers in this oligonucleotide synthesis market?
Q.8 What are the new developments in this oligonucleotide synthesis market? Which companies are leading these developments?
Q.9 Who are the major players in this oligonucleotide synthesis market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this oligonucleotide synthesis market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global oligonucleotide synthesis market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Offering (Synthesized Oligonucleotides, Reagents & Consumables, and Equipment), Application (Research, Diagnostics, Therapeutics), and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Oligonucleotide Synthesis Market Trends and Forecast
3.3: Global Oligonucleotide Synthesis Market by Offering
3.3.1: Synthesized Oligonucleotides
3.3.1.1: Products
3.3.1.1.1: Oligonucleotide-Based Drugs
3.3.1.1.2: Primers
3.3.1.1.3: Probes
3.3.1.1.4: Large-Scale Synthesis Oligonucleotides
3.3.1.1.5: Intermediate-Scale Synthesis Oligonucleotides
3.3.1.1.6: Linkers & Adaptors
3.3.1.2: Services
3.3.1.2.1: Custom Oligonucleotides
3.3.1.2.2: Pre-Designed Oligonucleotides
3.3.2: Reagents & Consumables
3.3.3: Equipment
3.4: Global Oligonucleotide Synthesis Market by Application
3.4.1: Research
3.4.1.1: PCR
3.4.1.2: qPCR
3.4.1.3: Sequencing
3.4.1.4: Gene Synthesis
3.4.1.5: Other Research Applications
3.4.2: Diagnostics
3.4.3: Therapeutics
3.4.3.1: DNA & Antisense Oligonucleotide-Based Therapies
3.4.3.2: RNAi Oligonucleotide-Based Therapies
3.4.3.3: CPG Oligonucleotide-Based Therapies
3.5: Global Oligonucleotide Synthesis Market by End User
3.5.1: Academic & Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Diagnostic Laboratories
3.5.4: Hospitals
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Oligonucleotide Synthesis Market by Region
4.2: North American Oligonucleotide Synthesis Market
4.2.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.2.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.2.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.2.4: The United States Oligonucleotide Synthesis Market
4.2.5: The Canadian Oligonucleotide Synthesis Market
4.2.6: The Mexican Oligonucleotide Synthesis Market
4.3: European Oligonucleotide Synthesis Market
4.3.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.3.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.3.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.3.5: The Oligonucleotide Synthesis Market of United Kingdom
4.3.5: The German Oligonucleotide Synthesis Market
4.3.6: The French Oligonucleotide Synthesis Market
4.4: APAC Oligonucleotide Synthesis Market
4.4.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.4.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.4.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.4.4: The Chinese Oligonucleotide Synthesis Market
4.4.5: The Indian Oligonucleotide Synthesis Market
4.4.6: The Japanese Oligonucleotide Synthesis Market
4.5: ROW Oligonucleotide Synthesis Market
4.5.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.5.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.5.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.5.4: Brazilian Oligonucleotide Synthesis Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Offering
7.1.2: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Application
7.1.3: Growth Opportunities for the Global Oligonucleotide Synthesis Market by End User
7.1.4: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Region
7.2: Emerging Trends in the Global Oligonucleotide Synthesis Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Oligonucleotide Synthesis Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oligonucleotide Synthesis Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: General Electric Company
8.2: Merck KGaA
8.3: Eurofins Scientific SE
8.4: Agilent Technologies
8.5: LGC Biosearch Technologies Inc.
8.6: Integrated DNA Technologies Inc.
8.7: GeneDesign Inc.
8.8: Nitt Denk Avecia Inc.
8.9: Trilink Biotechnologies LLC
8.10: Kaneka Eurogentec S.A
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Oligonucleotide Synthesis Market Trends and Forecast
3.3: Global Oligonucleotide Synthesis Market by Offering
3.3.1: Synthesized Oligonucleotides
3.3.1.1: Products
3.3.1.1.1: Oligonucleotide-Based Drugs
3.3.1.1.2: Primers
3.3.1.1.3: Probes
3.3.1.1.4: Large-Scale Synthesis Oligonucleotides
3.3.1.1.5: Intermediate-Scale Synthesis Oligonucleotides
3.3.1.1.6: Linkers & Adaptors
3.3.1.2: Services
3.3.1.2.1: Custom Oligonucleotides
3.3.1.2.2: Pre-Designed Oligonucleotides
3.3.2: Reagents & Consumables
3.3.3: Equipment
3.4: Global Oligonucleotide Synthesis Market by Application
3.4.1: Research
3.4.1.1: PCR
3.4.1.2: qPCR
3.4.1.3: Sequencing
3.4.1.4: Gene Synthesis
3.4.1.5: Other Research Applications
3.4.2: Diagnostics
3.4.3: Therapeutics
3.4.3.1: DNA & Antisense Oligonucleotide-Based Therapies
3.4.3.2: RNAi Oligonucleotide-Based Therapies
3.4.3.3: CPG Oligonucleotide-Based Therapies
3.5: Global Oligonucleotide Synthesis Market by End User
3.5.1: Academic & Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Diagnostic Laboratories
3.5.4: Hospitals
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Oligonucleotide Synthesis Market by Region
4.2: North American Oligonucleotide Synthesis Market
4.2.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.2.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.2.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.2.4: The United States Oligonucleotide Synthesis Market
4.2.5: The Canadian Oligonucleotide Synthesis Market
4.2.6: The Mexican Oligonucleotide Synthesis Market
4.3: European Oligonucleotide Synthesis Market
4.3.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.3.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.3.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.3.5: The Oligonucleotide Synthesis Market of United Kingdom
4.3.5: The German Oligonucleotide Synthesis Market
4.3.6: The French Oligonucleotide Synthesis Market
4.4: APAC Oligonucleotide Synthesis Market
4.4.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.4.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.4.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.4.4: The Chinese Oligonucleotide Synthesis Market
4.4.5: The Indian Oligonucleotide Synthesis Market
4.4.6: The Japanese Oligonucleotide Synthesis Market
4.5: ROW Oligonucleotide Synthesis Market
4.5.1: Market by Offering: Synthesized Oligonucleotides (Products (Oligonucleotide-Based Drugs, Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, and Linkers & Adaptors), Services (Custom Oligonucleotides and Pre-Designed Oligonucleotides), Reagents & Consumables, and Equipment
4.5.2: Market by Application: Research (PCR, qPCR, Sequencing, Gene Synthesis, and Other Research Applications), Diagnostics, Therapeutics (DNA & Antisense Oligonucleotide-Based Therapies, RNAi Oligonucleotide-Based Therapies, and CPG Oligonucleotide-Based Therapies)
4.5.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Hospitals
4.5.4: Brazilian Oligonucleotide Synthesis Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Offering
7.1.2: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Application
7.1.3: Growth Opportunities for the Global Oligonucleotide Synthesis Market by End User
7.1.4: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Region
7.2: Emerging Trends in the Global Oligonucleotide Synthesis Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Oligonucleotide Synthesis Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oligonucleotide Synthesis Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: General Electric Company
8.2: Merck KGaA
8.3: Eurofins Scientific SE
8.4: Agilent Technologies
8.5: LGC Biosearch Technologies Inc.
8.6: Integrated DNA Technologies Inc.
8.7: GeneDesign Inc.
8.8: Nitt Denk Avecia Inc.
8.9: Trilink Biotechnologies LLC
8.10: Kaneka Eurogentec S.A
